疫苗接种剂量之间的COVID-19再感染:巴西东南部一个城市的病例报告

M. S. Costa, Gabriel de Oliveira Gelape, André Barbosa de Andrade, Luiza Passini Vaz-Tostes, Madara da Silva Simões, Rhuan Braga Oliveira, N. S. Guimarães, U. Tupinambás
{"title":"疫苗接种剂量之间的COVID-19再感染:巴西东南部一个城市的病例报告","authors":"M. S. Costa, Gabriel de Oliveira Gelape, André Barbosa de Andrade, Luiza Passini Vaz-Tostes, Madara da Silva Simões, Rhuan Braga Oliveira, N. S. Guimarães, U. Tupinambás","doi":"10.17765/2176-9192.2021v23n2e10400","DOIUrl":null,"url":null,"abstract":"Vaccination against COVID-19 is happening worldwide, with most vaccines requiring 2 doses to reach its maximum potential. It is the most efficient measure to prevent new cases of COVID-19, both of infection and reinfection. This case reports the reinfection of a female receptionist at an urgent care facility, where the research group was testing and monitoring symptoms of patients with flu syndrome, in the city of Belo Horizonte, Minas Gerais, Brasil, where she reinfected between the two preconized doses. Her initial infection occurred in September 2020 and reinfection in February 2021, 14 days after the first dose - both confirmed by RT-PCR - with reportedly worse symptoms on the latter. We warn for the possibility of reinfection episodes even after the first dose of vaccination, differently from what literature stated so far, so that health agents can organize more effective security measures, in a context of viral mutation and of new strains. \n","PeriodicalId":30388,"journal":{"name":"Iniciacao Cientifica Cesumar","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19 REINFECTION BETWEEN DOSES OF VACCINATION: CASE REPORT IN A CITY OF BRAZIL’S SOUTHEAST\",\"authors\":\"M. S. Costa, Gabriel de Oliveira Gelape, André Barbosa de Andrade, Luiza Passini Vaz-Tostes, Madara da Silva Simões, Rhuan Braga Oliveira, N. S. Guimarães, U. Tupinambás\",\"doi\":\"10.17765/2176-9192.2021v23n2e10400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Vaccination against COVID-19 is happening worldwide, with most vaccines requiring 2 doses to reach its maximum potential. It is the most efficient measure to prevent new cases of COVID-19, both of infection and reinfection. This case reports the reinfection of a female receptionist at an urgent care facility, where the research group was testing and monitoring symptoms of patients with flu syndrome, in the city of Belo Horizonte, Minas Gerais, Brasil, where she reinfected between the two preconized doses. Her initial infection occurred in September 2020 and reinfection in February 2021, 14 days after the first dose - both confirmed by RT-PCR - with reportedly worse symptoms on the latter. We warn for the possibility of reinfection episodes even after the first dose of vaccination, differently from what literature stated so far, so that health agents can organize more effective security measures, in a context of viral mutation and of new strains. \\n\",\"PeriodicalId\":30388,\"journal\":{\"name\":\"Iniciacao Cientifica Cesumar\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iniciacao Cientifica Cesumar\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17765/2176-9192.2021v23n2e10400\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iniciacao Cientifica Cesumar","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17765/2176-9192.2021v23n2e10400","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

针对COVID-19的疫苗接种正在世界各地开展,大多数疫苗需要两剂才能发挥最大潜力。这是预防新发感染和再感染的最有效措施。该病例报告了一名女性接待员在巴西米纳斯吉拉斯州贝洛奥里藏特市的一家紧急护理机构再次感染,该研究小组在那里测试和监测流感综合征患者的症状,她在两次预注射剂量之间再次感染。她的初次感染发生在2020年9月,再次感染发生在2021年2月,即第一次注射后14天——两次均经RT-PCR证实——据报道,后者的症状更严重。我们警告说,即使在第一剂疫苗接种后,也有可能再次感染,这与迄今为止的文献所述不同,因此,在病毒突变和新菌株的背景下,卫生人员可以组织更有效的安全措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
COVID-19 REINFECTION BETWEEN DOSES OF VACCINATION: CASE REPORT IN A CITY OF BRAZIL’S SOUTHEAST
Vaccination against COVID-19 is happening worldwide, with most vaccines requiring 2 doses to reach its maximum potential. It is the most efficient measure to prevent new cases of COVID-19, both of infection and reinfection. This case reports the reinfection of a female receptionist at an urgent care facility, where the research group was testing and monitoring symptoms of patients with flu syndrome, in the city of Belo Horizonte, Minas Gerais, Brasil, where she reinfected between the two preconized doses. Her initial infection occurred in September 2020 and reinfection in February 2021, 14 days after the first dose - both confirmed by RT-PCR - with reportedly worse symptoms on the latter. We warn for the possibility of reinfection episodes even after the first dose of vaccination, differently from what literature stated so far, so that health agents can organize more effective security measures, in a context of viral mutation and of new strains.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信